Edition:
United Kingdom

Bellerophon Therapeutics Inc (BLPH.OQ)

BLPH.OQ on NASDAQ Stock Exchange Global Market

1.06USD
7:28pm BST
Change (% chg)

$-0.02 (-1.85%)
Prev Close
$1.08
Open
$1.08
Day's High
$1.08
Day's Low
$1.01
Volume
52,695
Avg. Vol
121,762
52-wk High
$3.30
52-wk Low
$0.47

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.200
Mar '18 0.00 0.057
FY 2017 Dec '17 0.00 -0.437
Sep '17 0.00 -0.217
Jun '17 0.00 -0.117
Mar '17 0.00 -0.599
FY 2016 Dec '16 0.00 -0.367
Sep '16 0.00 -0.303
Jun '16 0.00 -0.392
Mar '16 0.00 -0.541
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 1 0.00 0.00 0.00 --
Year Ending Dec-18 1 0.00 0.00 0.00 0.00
Year Ending Dec-19 1 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Dec-18 1 -0.13 -0.13 -0.13 --
Year Ending Dec-18 1 -0.40 -0.40 -0.40 -0.98
Year Ending Dec-19 1 -0.54 -0.54 -0.54 -1.17
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.92 33.73
P/E High - Last 5 Yrs. -- 289.06 45.21
P/E Low - Last 5 Yrs. -- 90.26 23.82
Beta -- 0.94 0.88
Price to Sales (TTM) -- 123.71 5.82
Price to Book (MRQ) -- 15.32 4.90
Price to Tangible Book (MRQ) -- 14.53 6.53
Price to Cash Flow (TTM) -- 70.52 22.98
% Owned Institutions 54.21 14.06 2.14

Dividends

  Company industry sector
Dividend Yield -- 0.33 1.51
Dividend Yield - 5 Year Avg -- 0.24 1.52
Dividend 5 Year Growth Rate -- 2.55 5.38
Payout Ratio(TTM) -- 16.85 43.95

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 413.79 8.03
Sales (TTM) vs TTM 1 Yr. Ago -- 103.76 5.76
Sales - 5 Yr. Growth Rate -- 30.82 9.89
EPS (MRQ) vs Qtr. 1 Yr. Ago 70.16 24.48 22.57
EPS (TTM) vs TTM 1 Yr. Ago 47.22 -- --
EPS - 5 Yr. Growth Rate -- 37.84 10.95
Capital Spending - 5 Yr. Growth Rate -- 38.59 14.94

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.94 2.25
Current Ratio (MRQ) 3.71 5.32 3.05
LT Debt to Equity (MRQ) -- 34.92 12.63
Total Debt to Equity (MRQ) -- 36.74 16.96
Interest Coverage (TTM) -- -97.26 37.54

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.17 54.92
Gross Margin - 5 Yr. Avg. -- 49.26 52.45
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -575.48 11.06
Operating Margin (TTM) -- -770.44 4.32
Operating Margin - 5 Yr. Avg. -- -595.77 6.41
Pre-Tax Margin (TTM) -- -732.46 5.37
Pre-Tax Margin - 5 Yr. Avg. -- -601.16 6.85
Net Profit Margin (TTM) -- -733.39 1.64
Net Profit Margin - 5 Yr. Avg. -- -604.13 3.10
Effective Tax Rate (TTM) -- 23.66 23.23
Effective Tax Rate - 5 Yr. Avg. -- 18.81 24.11

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 22,811,841 812,819,528
Net Income/Employee (TTM) -- 1,720,762 95,602,483
Receivable Turnover (TTM) -- 19.83 5.78
Inventory Turnover (TTM) -- 2.38 3.60
Asset Turnover (TTM) 0.00 0.40 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -142.66 -1.05 10.93
Return on Assets - 5 Yr. Avg. -- 3.23 12.05
Return on Investment (TTM) -187.88 0.63 14.31
Return on Investment - 5 Yr. Avg. -- 2.31 15.65
Return on Equity (TTM) -359.90 1.68 16.04
Return on Equity - 5 Yr. Avg. -- 3.16 16.92
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 58.24 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Bellerophon Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 33.62 29.01 99 60
13 Week 6.90 1.69 99 64
26 Week 17.42 8.50 99 77
52 Week 9.93 -6.83 99 47
YTD 197.96 161.67 99 56
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 66.00%
# of Holders: 35
Total Shares Held: 38,147,173
3 Mo. Net Change: 2,324,320
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 1
# Reduced Positions: 1
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.